These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9140169)

  • 1. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes.
    Blajchman MA; Lee DH
    Transfus Med Rev; 1997 Apr; 11(2):95-105. PubMed ID: 9140169
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits.
    McGill M; Fugman DA; Vittorio N; Darrow C
    J Lab Clin Med; 1987 Feb; 109(2):127-33. PubMed ID: 3805864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism triggering platelet hemostatic plug formation in vivo.
    Sakon M; Hawiger J
    Trans Assoc Am Physicians; 1984; 97():311-8. PubMed ID: 6535347
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
    Levi M; Friederich PW; Middleton S; de Groot PG; Wu YP; Harris R; Biemond BJ; Heijnen HF; Levin J; ten Cate JW
    Nat Med; 1999 Jan; 5(1):107-11. PubMed ID: 9883848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of phospholipids (Fibraccel) for hemostasis in thrombocytopenic-thrombocytopathic patients].
    Dietrich G; Söhngen D; Kretschmer V
    Beitr Infusionsther; 1990; 26():183-5. PubMed ID: 1703825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates.
    Escolar G; Mazzara R; White JG; Castillo R; Ordinas A
    Blood Cells; 1992; 18(3):403-15; discussion 416-20. PubMed ID: 1286195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. o-raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits.
    Lee DH; Bardossy L; Peterson N; Blajchman MA
    Blood; 2000 Nov; 96(10):3630-6. PubMed ID: 11071664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model.
    Krishnamurti C; Maglasang P; Rothwell SW
    Transfusion; 1999 Sep; 39(9):967-74. PubMed ID: 10533823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients.
    Buyukasik Y; Goker H; Buyukasik NS; Sayinalp N; Haznedaroglu IC; Ozcebe OI
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):633-7. PubMed ID: 18832902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVBT-documented platelet function correlates with flow cytometric data.
    Hoffmann J; Bonacker G; Kretschmer V; Schulzki T; Heimanns J
    Transfus Sci; 1996 Dec; 17(4):553-8. PubMed ID: 10168553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C.
    Filip DJ; Aster RH
    J Lab Clin Med; 1978 Apr; 91(4):618-24. PubMed ID: 641387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of cortisone in healthy dogs with physiological thrombocyte count and prolonged aspirin-induced bleeding time and in dogs with a picture of thrombocytopenic disease].
    Ammelounx U; Nolte I
    Berl Munch Tierarztl Wochenschr; 1987 Apr; 100(4):124-9. PubMed ID: 3593195
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits.
    Okamura Y; Fujie T; Nogawa M; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Transfus Med; 2008 Jun; 18(3):158-66. PubMed ID: 18598278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal thrombocytopenia.
    Andrew M; Kelton J
    Clin Perinatol; 1984 Jun; 11(2):359-91. PubMed ID: 6378484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
    Okamura Y; Takeoka S; Teramura Y; Maruyama H; Tsuchida E; Handa M; Ikeda Y
    Transfusion; 2005 Jul; 45(7):1221-8. PubMed ID: 15987370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.
    Blajchman MA; Senyi AF; Hirsh J; Surya Y; Buchanan M; Mustard JF
    J Clin Invest; 1979 May; 63(5):1026-35. PubMed ID: 376547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions.
    Larsen OH; Ingerslev J; Sørensen B
    Ann Hematol; 2007 Mar; 86(3):217-21. PubMed ID: 17119964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
    André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
    Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets.
    Chao FC; Kim BK; Houranieh AM; Liang FH; Konrad MW; Swisher SN; Tullis JL
    Transfusion; 1996 Jun; 36(6):536-42. PubMed ID: 8669086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.